1. Home
  2. HCI vs AVDL Comparison

HCI vs AVDL Comparison

Compare HCI & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HCI Group Inc.

HCI

HCI Group Inc.

HOLD

Current Price

$173.90

Market Cap

2.2B

Sector

Finance

ML Signal

HOLD

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.31

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCI
AVDL
Founded
2006
2015
Country
United States
Ireland
Employees
552
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.1B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
HCI
AVDL
Price
$173.90
$21.31
Analyst Decision
Strong Buy
Buy
Analyst Count
5
9
Target Price
$230.00
$18.38
AVG Volume (30 Days)
166.1K
2.8M
Earning Date
11-06-2025
11-04-2025
Dividend Yield
0.93%
N/A
EPS Growth
32.29
N/A
EPS
15.80
N/A
Revenue
$816,578,000.00
$248,517,000.00
Revenue This Year
$19.65
$65.47
Revenue Next Year
$9.97
$30.88
P/E Ratio
$10.94
N/A
Revenue Growth
8.75
79.88
52 Week Low
$106.89
$6.38
52 Week High
$210.50
$23.57

Technical Indicators

Market Signals
Indicator
HCI
AVDL
Relative Strength Index (RSI) 41.79 58.90
Support Level $168.93 $21.32
Resistance Level $181.51 $21.62
Average True Range (ATR) 5.64 0.29
MACD -0.05 -0.31
Stochastic Oscillator 36.92 6.90

Price Performance

Historical Comparison
HCI
AVDL

About HCI HCI Group Inc.

HCI Group Inc is engaged in the property and casualty insurance business through two Florida domiciled insurance companies, Homeowners Choice Property & Casualty Insurance Company (HCPCI) and TypTap Insurance Company (TypTap). Both HCPCI and TypTap are authorized to underwrite various homeowners' property and casualty insurance products and allied lines business in the state of Florida and other states. The operating segments of the group are insurance operations, TypTap Group, reciprocal exchange operations, real estate operations, and corporate and other. It derives key revenue from the HCPCI Insurance operation segment.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: